Decheng Capital LLC Diversified Active

Location: Menlo Park, CA

CIK: 0002010850 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 8, 2025

Total Value: $356M (100.0% shares, 0.0% debt)

Holdings (27)

CGON CG ONCOLOGY INC 43.8%
Value $156M Shares 6,371,669 Est. Cost $39.91 Unrealized -29.5%
NUVB Nuvation Bio Inc. 12.8%
Value $45.68M Shares 25,954,439 Est. Cost $3.05 Unrealized -25.4%
AARD AARDVARK THERAPEUTICS INC 8.3%
Value $29.42M Shares 3,917,299 Est. Cost $11.23 Unrealized 0.0%
UPB Upstream Bio Inc. 5.6%
Value $20.11M Shares 3,285,293 Est. Cost $22.33 Unrealized -57.2%
NAMS NEWAMSTERDAM PHARMA CO NV 4.4%
Value $15.76M Shares 770,000 Est. Cost $19.66 Unrealized +13.1%
KRYS KRYSTAL BIOTECH INC 3.3%
Value $11.72M Shares 65,000 Est. Cost $121.63 Unrealized +38.3%
RVMD REVOLUTION MEDICINES INC(NSM) 2.2%
Value $7.991M Shares 226,000 Est. Cost $50.40 Unrealized -19.5%
MERUS NV 2.2%
Value $7.959M Shares 189,098 Est. Cost $51.07 Unrealized
BYSI BeyondSpring Inc. 2.0%
Value $6.972M Shares 4,882,651 Est. Cost $0.92 Unrealized +83.6%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 1.9%
Value $6.704M Shares 171,600 Est. Cost $50.34 Unrealized
Lyell Immunopharma, Inc. 1.8%
Value $6.407M Shares 11,909,341 Est. Cost $0.64 Unrealized
RCUS Arcus Biosciences, Inc 1.8%
Value $6.349M Shares 808,789 Est. Cost $15.98 Unrealized -27.5%
ACRS Aclaris Therapeutics, Inc. 1.7%
Value $6.184M Shares 4,041,736 Est. Cost $2.33 Unrealized -8.5%
CRNX CRINETICS PHARMACEUTICALS IN 1.7%
Value $5.969M Shares 177,958 Est. Cost $39.97 Unrealized -6.6%
CYTK CYTOKINETICS INC 1.1%
Value $4.019M Shares 100,000 Est. Cost $75.83 Unrealized -39.4%
LEGN LEGEND BIOTECH CORP-ADR 1.0%
Value $3.393M Shares 100,000 Est. Cost $47.77 Unrealized
ACLX ARCELLX INC 0.9%
Value $3.28M Shares 50,000 Est. Cost $81.25 Unrealized -16.6%
ZNTL Zentalis Pharmaceuticals Inc. 0.9%
Value $3.211M Shares 2,019,762 Est. Cost $13.39 Unrealized -83.9%
AURA Aura Biosciences, Inc. 0.8%
Value $3.021M Shares 515,555 Est. Cost $8.47 Unrealized -10.7%
BNTX Biontech SE-ADR 0.5%
Value $1.821M Shares 20,000 Est. Cost $113.95 Unrealized
EQ Equillium Inc. 0.5%
Value $1.745M Shares 4,447,308 Est. Cost $0.59 Unrealized +25.4%
FDMT 4D MOLECULAR THERAPEUTICS IN 0.3%
Value $1.084M Shares 335,515 Est. Cost $24.39 Unrealized -80.7%
ILMN Illumnia, Inc. 0.3%
Value $932K Shares 11,749 Est. Cost $122.34 Unrealized -11.5%
PYXS Pyxis Oncology, Inc (formerly Apexigen) 0.1%
Value $320K Shares 326,810 Est. Cost $1.71 Unrealized -22.1%
GRAL GRAIL INC 0.1%
Value $247K Shares 9,684 Est. Cost $16.22 Unrealized +90.5%
VERA VERA THERAPEUTICS INC 0.0%
Value $108K Shares 4,495 Est. Cost $39.67 Unrealized -19.0%
Nuvation Bio Inc. 0.0%
Value $43,990 Shares 646,057 Est. Cost $0.16 Unrealized